We are live on ! Find out more
AVXL icon

Anavex Life Sciences
AVXL

46 hedge funds and large institutions have $23.4M invested in Anavex Life Sciences in 2016 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

141% more capital invested

Capital invested by funds: $9.71M → $23.4M (+$13.7M)

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

18% more funds holding

Funds holding: 39 → 46 (+7)

26% less call options, than puts

Call options by funds: $851K | Put options by funds: $1.15M

Holders
46
Holders Change
+7
Holders Change %
+17.95%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
11
Reduced
9
Closed
12
Calls
$851K
Puts
$1.15M
Net Calls
-$299K
Net Calls Change
-$298K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$4.08M
2
BIT
BlackRock Institutional Trust
California
+$1.37M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$796K
4
BIM
BlackRock Investment Management
Delaware
+$614K
5
Bank of America
Bank of America
North Carolina
+$486K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$564K
2
Millennium Management
Millennium Management
New York
-$305K
3
UBS Group
UBS Group
Switzerland
-$258K
4
CS
Credit Suisse
Switzerland
-$250K
5
HCM
Highbridge Capital Management
New York
-$248K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
26
Virtu KCG Holdings
New York
$91K +$72.1K +14,918 New
VOYA Investment Management
27
VOYA Investment Management
Georgia
$90K +$70.8K +14,653 New
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$88K +$69.8K +14,454 New
AIM
29
Acrospire Investment Management
Illinois
$87K +$51.2K +10,600 +294%
BA
30
BlackRock Advisors
Delaware
$85K +$49.4K +10,220 +280%
Creative Planning
31
Creative Planning
Kansas
$72K – – –
SO
32
STRS Ohio
Ohio
$66K +$52.7K +10,900 New
CG
33
Cutler Group
California
$55K +$9.18K +1,900 +26%
Morgan Stanley
34
Morgan Stanley
New York
$36K -$114K -23,690 -80%
Citigroup
35
Citigroup
New York
$33K +$26.5K +5,492 New
Deutsche Bank
36
Deutsche Bank
Germany
$30K -$79.8K -16,509 -76%
LTFS
37
Ladenburg Thalmann Financial Services
Florida
$24K – – –
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
$12K – – –
BlackRock
39
BlackRock
New York
$8K +$6.49K +1,344 New
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$7.89K +$6.24K +1,291 New
Wells Fargo
41
Wells Fargo
California
$6K -$13.3K -2,763 -74%
TRCT
42
Tower Research Capital (TRC)
New York
$5K -$48.3K -10,003 -92%
AA
43
AlphaMark Advisors
Kentucky
$4K – – –
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$2K – – –
TIM
45
Tortoise Investment Management
New York
$2K – – –
Millennium Management
46
Millennium Management
New York
– -$305K -62,188 Closed
HCM
47
Highbridge Capital Management
New York
– -$248K -50,704 Closed
SCM
48
Segantii Capital Management
Hong Kong
– -$211K -42,808 Closed
Nomura Holdings
49
Nomura Holdings
Japan
– -$152K -31,168 Closed
AL
50
Airain Ltd
Guernsey
– -$135K -27,466 Closed
1
2
3

AVXL Hedge Fund Activity: Q2 2016 in Review

46 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q2 2016, worth a combined $23.4M — up 141% from $9.71M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new AVXL positions and 12 closed out — a net gain of 7 holders — while 11 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $4.08M. The largest seller was Susquehanna International Group, cutting an estimated $564K.

  • 46 institutional investors held Anavex Life Sciences (AVXL) as of Q2 2016, up from 39 in Q1 2016.
  • Funds reported $23.4M of Anavex Life Sciences stock for Q2 2016, up 141% quarter-over-quarter.
  • 19 funds opened new Anavex Life Sciences positions in Q2 2016 and 12 closed out, a net change of +7 holders.
  • The largest Anavex Life Sciences buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $4.08M added.
  • The largest Anavex Life Sciences seller in Q2 2016 was Susquehanna International Group, an estimated $564K sold.

Based on aggregated 13F filings for Q2 2016.